Skip to main content

Milestone 1.B

Quantify the exposome in existing and new AD cohorts to gain a more precise measure of environmental exposure factors and their relationship to AD risk and individual trajectories of disease progression. These studies should employ a life-course approach across diverse populations (e.g., race, ethnicity, immigration status, geographical region, education, age, gender) and incorporate methods aimed at understanding how ancestry, race/ethnicity and socioeconomic disparities interact with exposome factors to modulate AD risk.

Success Criteria

  • Provide supplemental funding to at least 6 clinical research studies to explore the impact of environmental exposure on the pathogenesis of AD and AD-related dementias and on responsiveness to treatment.

  • Launch at least three clinical research studies that incorporate deep molecular phenotyping, new environmental and behavioral sensors and cognitive assessment technologies to detect the impact of the exposome on AD risk and resilience. 

  • Provide funding to enhance existing data resources with information on early life exposures/events.

  • Provide funding to enhance administrative data linkages.

Summary of Key Accomplishments

NIA supports nationally representative cohorts that capture data on environmental factors for dementia risk, including the Health and Retirement Study (HRS), Harmonized Cognitive Assessment Protocol (HCAP) in the U.S. NIA also supports studies harmonized to HRS in several other countries. HRS collects demographic information and blood samples for people age 51 and older. The HCAP enables researchers to measure and understand dementia risk in ongoing longitudinal studies of aging around the world by using similar methods.

NIA also supports educational cohort studies seeking to understand education and other social factors as risk and protective factors for dementia across the life course. NIA has also launched a new funding initiative to enhance measures of educational exposures and cognitive assessments in existing studies to support this work.

This information is current as of March 2022.

Research Implementation Area
Population Studies and Precision Medicine
In Progress

Accomplishments/Implementation Activities

Funding Initiatives

Research Programs and Resources

Research Highlights

Relevant Recommendations